Pancreatic Cancer Research

ResearcherUniversity of Electronic Science and Technology of ChinaActive in the last 2 years

Peng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9026-9999; OpenAlex author ID A5100432747. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Real-time fluorescence-assisted semi-ex vivo intestinal autotransplantation for pancreatic adenocarcinoma patients with mesenteric root invasion (with video). Co-author DOI 10.1016/j.hbpd.2024.07.003↗
  2. Mediastinum metastasis in a post-surgical pancreatic cancer patient successfully confirmed with endoscopic ultrasonography. Last author DOI 10.5847/wjem.j.1920-8642.2021.03.017↗
  3. Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancer. Co-author DOI 10.1111/jphp.12941↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yu Zhang · 1 shared paper, 2025 · strength 0.27
  2. Chong Yang · 1 shared paper, 2025 · strength 0.27
  3. Wan Yee Lau · 1 shared paper, 2025 · strength 0.27
  4. Xin-Yu You · 1 shared paper, 2025 · strength 0.27
  5. Hongtao Wei · 1 shared paper, 2021 · strength 0.22
  6. Jing Du · 1 shared paper, 2019 · strength 0.11
  7. Yong Han · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.